Table 2.
Biomarker | CSF | Blood/Plasma | Saliva | |
---|---|---|---|---|
AD specific biomarkers (Aβ and TAU) | Aβ isoforms: | |||
Aβ1-42 | ↓ | Inconsistency | ↑ | |
Aβ1-40 | Inconsistency | Inconsistency | Unchanged | |
Aβ1-38 | Inconsistency | Inconsistency | No data | |
Aβ1-42/Aβ1-40 ratio | ↓ | ↓ | No data | |
Aβ1-42/Aβ1-38 ratio | ↓ | No data | No data | |
TAU | ||||
t-TAU | ↑ | ↑ | ↓ | |
p-TAU | ↑ | ↑ | ↑ | |
AD non-specific biomarkers
Non-Aβ and non-TAU biomarkers |
Inflammation/neuroinflammation biomarkers: | |||
TREM2 | ↑ | No change | No data | |
YKL-40 | ↑ | ↑ | No data | |
IP-10 | Inconsistent | Inconsistent | No data | |
ICAM1 | ↑ | No data | No data | |
Synaptic dysfunction biomarkers: | ||||
Neurogranin * | ↑ | No change | No data | |
SNAP-25 | ↑ | No data | No data | |
Synaptotagmin | ↑ | ↓ (limited data) | No data | |
Secretogranin-2 | ↓ | No data | No data | |
Neuronal pentraxin 1 | ↓ | No data | No data | |
Neurofascin | ↓ | No data | No data | |
Myelin basic protein | ↑ | No data | No data | |
BACE1 | ↑ | ↑ | No data | |
α-Synuclein | ↑ | No change | No data | |
TDP-43 | No data | ↑ | No data | |
Lactoferrin | No data | No data | ↓ | |
Acetylcholinesterase | No data | No data | ↓ | |
Neuronal injury biomarkers: | ||||
NFL | ↑ | ↑ | No data | |
VILIP-1 | ↑ | ↑ | No data | |
Iron toxicity biomarkers: | ||||
Ferritin | ↑ | No change | No data | |
hFABP | ↑ | No change | No data |
↓: decreased level in AD compared to controls; ↑: increased level in AD compared to controls; TREM2, triggering receptor expressed on myeloid cells 2; YKL-40, Chitinase-3-like protein 1; IP-10, interferon-γ-induced protein 10; ICAM1, intercellular adhesion molecule 1; *, potentially high degree of AD specificity; SNAP-25, synaptosome-associated protein 25; BACE1, β-site amyloid precursor protein cleaving enzyme 1; TDP-43, transactive response DNA-binding protein 43; NFL, neurofilament light polypeptide; VILIP-1, visinin-like protein 1; hFABP, heart-type fatty acid-binding protein.